IOVANCE BIOTHERAPEUTICS, INC. reports

Company location: San Carlos, CA
Fiscal year end: 31 December

IOVANCE BIOTHERAPEUTICS, INC. has filed 1,025 SEC EDGAR filings since 29 Jan 2008

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G

SEC filing history

Showing 976-998 of 998 matching filings.

Per page

Current page

D File 021-150136

D filing

Filing date: 08 Nov 2010
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13D/A File 005-85384

HAMILTON ATLANTIC

Filing date: 05 Nov 2010
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G File 005-85384

BRISTOL INVESTMENT FUND, LTD.

Filing date: 05 Nov 2010
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

PRIMARY DOCUMENT

Filing date: 04 Nov 2010
Reporting date: 31 Mar 2010
SEC evidence: Open document Open filing
Next action: Verify source filing

PRIMARY DOCUMENT

Filing date: 04 Nov 2010
Reporting date: 15 Mar 2010
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 000-53127

8-K filing

Filing date: 28 Oct 2010
Reporting date: 22 Oct 2010
SEC evidence: Open document Open filing
Next action: Verify source filing

D File 021-148434

D filing

Filing date: 01 Oct 2010
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 000-53127

8-K filing

Filing date: 23 Sep 2010
Reporting date: 17 Sep 2010
SEC evidence: Open document Open filing
Next action: Verify source filing

10-Q File 000-53127

10-Q filing

Filing date: 16 Aug 2010
Reporting date: 30 Jun 2010
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K/A File 000-53127

8-K/A filing

Filing date: 06 Jul 2010
Reporting date: 15 Mar 2010
SEC evidence: Open document Open filing
Next action: Verify source filing

CT ORDER File 000-53127

CT ORDER filing

Filing date: 10 Jun 2010
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

4 filing

Filing date: 28 May 2010
Reporting date: 26 May 2010
SEC evidence: Open document Open filing
Next action: Verify source filing

10-Q File 000-53127

10-Q filing

Filing date: 14 May 2010
Reporting date: 31 Mar 2010
SEC evidence: Open document Open filing
Next action: Verify source filing

3 filing

Filing date: 08 Apr 2010
Reporting date: 29 Mar 2010
SEC evidence: Open document Open filing
Next action: Verify source filing

10-K File 000-53127

10-K filing

Filing date: 31 Mar 2010
Reporting date: 31 Dec 2009
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13D File 005-85384

HAMILTON ATLANTIC

Filing date: 29 Mar 2010
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13D File 005-85384

SC 13D filing

Filing date: 24 Mar 2010
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

3 filing

Filing date: 22 Mar 2010
Reporting date: 15 Mar 2010
SEC evidence: Open document Open filing
Next action: Verify source filing

3 filing

Filing date: 22 Mar 2010
Reporting date: 15 Mar 2010
SEC evidence: Open document Open filing
Next action: Verify source filing

4 filing

Filing date: 22 Mar 2010
Reporting date: 18 Mar 2010
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 14F1 File 005-85384

14F-1 OF GENESIS BIOPHARMA, INC.

Filing date: 19 Mar 2010
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 000-53127

CURRENT REPORT DATED 3-15-10

Filing date: 19 Mar 2010
Reporting date: 15 Mar 2010
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 000-53127

CURRENT REPORT DATED 3-5-10

Filing date: 08 Mar 2010
Reporting date: 05 Mar 2010
SEC evidence: Open document Open filing
Next action: Verify source filing